Lataa...
Pharmacodynamic Separation of Gemcitabine and Erlotinib in Locally Advanced or Metastatic Pancreatic Cancer: Therapeutic and Biomarker Results
PURPOSE: Erlotinib marginally improves survival when administered continuously with gemcitabine to patients with advanced pancreatic cancer; however, preclinical data suggest that there is antagonism between chemotherapy and Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors when the...
Tallennettuna:
| Julkaisussa: | Int J Clin Oncol |
|---|---|
| Päätekijät: | , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318776/ https://ncbi.nlm.nih.gov/pubmed/25091263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-014-0730-2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|